EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of BAS-1, a novel class A β-lactamase encoded in Bacteroides thetaiotaomicron

María Aznar Fernández, María José Gómez Gómez, José Miguel Cisneros iD, José Antonio Lepe, José Manuel Ortiz de la Rosa iD

Antimicrobial Agents and Chemotherapy · 05.08.2026 · 70 (8)

DOI: 10.1128/aac.00391-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.08.2026. Verfasst von María Aznar Fernández und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain. Hauptthemen laut MEDLINE: beta-Lactamases, Bacteroides thetaiotaomicron, Anti-Bacterial Agents. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Subprograme Rio Hortega, Instituto de Salud Carlos III and Europan Union, Subprograme Miguel Servet, Instituto de Salud Carlos III and European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We characterized a novel class A β-lactamase (BAS-1) in a pan-β-lactam-resistant Bacteroides thetaiotaomicron clinical isolate. Whole-genome sequencing identified bla BAS-1 within a mobile genetic element associated with IS 4351 . Cloning, susceptibility testing, β-lactam inactivation method, and half-maximal inhibitory concentration assay confirmed resistance to penicillins, cephalosporins, monobactams, and reduced susceptibility to the β-lactamase inhibitors. To date, no class A β-lactamase from Bacteroides has been shown to display such a resistant profile, challenging the assumed reliability of β-lactam/β-lactamase inhibitor combinations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesBacteroides thetaiotaomicronAnti-Bacterial AgentsMicrobial Sensitivity TestsCephalosporinsbeta-Lactamase InhibitorsHumansPenicillinsbeta-LactamsMonobactamsbeta-Lactam Resistance

Stichwörter der Autor:innen

Bacteroides thetaiotaomicronblaBAS-1novel β-lactamaseresistance mechanisms

Substanzen

beta-LactamasesAnti-Bacterial AgentsCephalosporinsbeta-Lactamase InhibitorsPenicillinsbeta-LactamsMonobactams

Autor:innen und Institutionen

  • Clinical Unit of Infectious Diseases, Microbiology and Parasitology, University Hospital Virgen del Rocío, Seville, Spain.
  • Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
  • Department of Medicine, Faculty of Medicine, University of Seville, Seville, Spain.
  • Department of Microbiology, Faculty of Medicine, University of Seville, Seville, Spain.

ORCID-Profile: José Miguel Cisneros, José Manuel Ortiz de la Rosa

Förderung

  • Instituto de Salud Carlos III
  • Subprograme Rio Hortega, Instituto de Salud Carlos III and Europan Union
  • Subprograme Miguel Servet, Instituto de Salud Carlos III and European Union

Zitieren

APA

Fernández, M. A., Gómez Gómez, M. J., Cisneros, J. M., Lepe, J. A., & Ortiz de la Rosa, J. M. (2026). Characterization of BAS-1, a novel class A β-lactamase encoded in Bacteroides thetaiotaomicron. Antimicrobial Agents and Chemotherapy, 70(8). https://doi.org/10.1128/aac.00391-26

Vancouver

Fernández MA, Gómez Gómez MJ, Cisneros JM, Lepe JA, Ortiz de la Rosa JM. Characterization of BAS-1, a novel class A β-lactamase encoded in Bacteroides thetaiotaomicron. Antimicrobial Agents and Chemotherapy. 2026;70(8). doi:10.1128/aac.00391-26

BibTeX
@article{Fernndez2026,
  author = {Fernández, María Aznar and Gómez Gómez, María José and Cisneros, José Miguel and Lepe, José Antonio and Ortiz de la Rosa, José Manuel},
  title = {Characterization of BAS-1, a novel class A β-lactamase encoded in Bacteroides thetaiotaomicron},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {8},
  doi = {10.1128/aac.00391-26}
}
Kostenlos starten →